Why Two Wall Street Titans Love BioMarin Pharma By: Benzinga via Benzinga August 04, 2015 at 09:17 AM EDT In a report published Tuesday, Piper Jaffray analyst Joshua E. Schimmer maintained an Overweight rating on BioMarin Pharmaceutical Inc ... Read More >> Related Stocks: Biomarin Pharmaceuticals